Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 17.30
+0.40 (2.37%)
Feb 20, 2026, 1:44 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 23.18 million as of February 20, 2026. Its market cap has decreased by -36.62% in one year.
Market Cap
23.18M
Enterprise Value
17.20M
Revenue
17.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.30
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 23.18M, a decrease of -61.23%. That is a compound annual growth rate of -4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 23.18M | 3.59% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 125.18B |
| Danel (Adir Yeoshua) | 2.68B |
| BrainsWay | 1.55B |
| Kamada | 1.54B |
| BioLight Life Sciences | 28.27M |
| Identi Healthcare | 27.79M |
| Nextage Therapeutics | 26.25M |
| XTL Biopharmaceuticals | 25.55M |